Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × Abiraterone Acetate × Clear all

Sponsor

Conditions

Prostatic Neoplasms 62 Neoplasm Metastasis 6 Prostatic Neoplasms, Castration-Resistant 4 Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 Prostate Cancer Metastatic 2 Breast Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Metastatic Castration-sensitive Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Hyperaldosteronism 1 Castration-resistant Prostate Cancer 1 Adenocarcinoma 1

Interventions

Paclitaxel 80 Carboplatin 76 Bevacizumab 53 Gemcitabine 29 pembrolizumab 27 liposomal doxorubicin 27 Topotecan 22 olaparib 19 Taxes 17 niraparib 15 Docetaxel 15 Immunoglobulin G 14 Disulfides 14 Cyclophosphamide 14 Cisplatin 11 durvalumab 10 Nivolumab 9 Doxorubicin 8 Albumin-Bound Paclitaxel 8 sargramostim 7 rucaparib 7 fludarabine phosphate 7 fludarabine 7 pazopanib 6 epacadostat 6 avelumab 6 Trabectedin 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 Interleukin-2 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡